Whistleblower Success for Claudine Q. Homolash
Astellas Pharma US Inc. to Pay $7.3 Million to Resolve False Claims Act Allegations for Off-Label Marketing and Promotion of Drug Mycamine®
The Pharmaceutical company Astellas Pharma US, Inc. has agreed to pay the United States a total of $7.3 million to resolve allegations that it violated the False Claims Act by illegally marketing and promoting the drug Mycamine® for pediatric use and to pediatric institutions.
The settlement resolves allegations brought in a whistleblower action filed in the Eastern District […] Read More
Going It Alone – Claudine Homolash Quoted In The Legal Intelligencer
In yesterday’s The Legal Intelligencer daily newspaper, I was quoted alongside other attorneys about Attorneys Leaving Firms in Search of New Business Models. The article discusses the shift in legal business models and how attorneys are finding new, creative ways to service their clients most effectively.